03:53 AM EDT, 04/09/2025 (MT Newswires) -- (Updates with a statement from the European Federation of Pharmaceutical Industries and Associations throughout.)

European pharmaceutical companies and their lobbyists warned European Union President Ursula von der Leyen that US President Donald Trump's tariffs will encourage more and more biotech firms to migrate to the US unless the bloc makes changes, the European Federation of Pharmaceutical Industries and Associations said in a statement Tuesday.

The association said that executives warned Von der Leyen "that unless Europe delivers rapid, radical policy change then pharmaceutical research, development and manufacturing is increasingly likely to be directed towards the US."

To stop the departure, the EU needs to better reward innovation, strengthen Europe's intellectual property provisions, adopt a regulatory framework "conducive to innovation," and ensure "policy coherence" across legislation.